Literature DB >> 21966353

Chikungunya virus: evolution and genetic determinants of emergence.

Konstantin A Tsetsarkin1, Rubing Chen, Michael B Sherman, Scott C Weaver.   

Abstract

Chikungunya virus (CHIKV) causes a severe and often persistent arthralgic disease that is occasionally fatal. A mosquito-borne virus, CHIKV exists in enzootic, non-human primate cycles in Africa, but occasionally emerges into urban, human cycles to cause major epidemics. Between 1920 and 1950, and again in 2005, CHIKV emerged into India and Southeast Asia, where major urban epidemics ensued. Unlike the early introduction, the 2005 emergence was accompanied by an adaptive mutation that allowed CHIKV to exploit a new epidemic vector, Aedes albopictus, via an A226V substitution in the E1 envelope glycoprotein. However, recent reverse genetic studies indicate that lineage-specific epistatic restrictions can prevent this from exerting its phenotype on mosquito infectivity. Thus, the A. albopictus-adaptive A226V substitution that is facilitating the dramatic geographic spread CHIKV epidemics, was prevented for decades or longer from being selected in most African enzootic strains as well as in the older endemic Asian lineage.

Entities:  

Mesh:

Year:  2011        PMID: 21966353      PMCID: PMC3182774          DOI: 10.1016/j.coviro.2011.07.004

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  50 in total

1.  [Epidemic of Chikungunya virus in 1999 and 200 in the Democratic Republic of the Congo].

Authors:  J J Muyembe-Tamfum; C N Peyrefitte; R Yogolelo; E Mathina Basisya; D Koyange; E Pukuta; M Mashako; H Tolou; J P Durand
Journal:  Med Trop (Mars)       Date:  2003

Review 2.  Class II virus membrane fusion proteins.

Authors:  Margaret Kielian
Journal:  Virology       Date:  2006-01-05       Impact factor: 3.616

3.  Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218.

Authors:  R Edelman; C O Tacket; S S Wasserman; S A Bodison; J G Perry; J A Mangiafico
Journal:  Am J Trop Med Hyg       Date:  2000-06       Impact factor: 2.345

4.  Chikungunya and dengue: a case of mistaken identity?

Authors:  D E Carey
Journal:  J Hist Med Allied Sci       Date:  1971-07       Impact factor: 2.088

5.  Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography.

Authors:  James E Voss; Marie-Christine Vaney; Stéphane Duquerroy; Clemens Vonrhein; Christine Girard-Blanc; Elodie Crublet; Andrew Thompson; Gérard Bricogne; Félix A Rey
Journal:  Nature       Date:  2010-12-02       Impact factor: 49.962

6.  Vectors of Chikungunya virus in Senegal: current data and transmission cycles.

Authors:  M Diallo; J Thonnon; M Traore-Lamizana; D Fontenille
Journal:  Am J Trop Med Hyg       Date:  1999-02       Impact factor: 2.345

7.  Tracking the re-emergence of epidemic chikungunya virus in Indonesia.

Authors:  Kanti Laras; Nono C Sukri; Ria P Larasati; Michael J Bangs; Rizal Kosim; Tony Wandra; John Master; Herman Kosasih; Sri Hartati; Charmagne Beckett; Endang R Sedyaningsih; H James Beecham; Andrew L Corwin
Journal:  Trans R Soc Trop Med Hyg       Date:  2005-02       Impact factor: 2.184

Review 8.  Critical review of the vector status of Aedes albopictus.

Authors:  N G Gratz
Journal:  Med Vet Entomol       Date:  2004-09       Impact factor: 2.739

9.  Chikungunya disease outbreak, Reunion Island.

Authors:  Loïc Josseran; Christophe Paquet; Abdelkrim Zehgnoun; Nadège Caillere; Alain Le Tertre; Jean-Louis Solet; Martine Ledrans
Journal:  Emerg Infect Dis       Date:  2006-12       Impact factor: 6.883

10.  Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak.

Authors:  Isabelle Schuffenecker; Isabelle Iteman; Alain Michault; Séverine Murri; Lionel Frangeul; Marie-Christine Vaney; Rachel Lavenir; Nathalie Pardigon; Jean-Marc Reynes; François Pettinelli; Leon Biscornet; Laure Diancourt; Stéphanie Michel; Stéphane Duquerroy; Ghislaine Guigon; Marie-Pascale Frenkiel; Anne-Claire Bréhin; Nadège Cubito; Philippe Desprès; Frank Kunst; Félix A Rey; Hervé Zeller; Sylvain Brisse
Journal:  PLoS Med       Date:  2006-05-23       Impact factor: 11.069

View more
  85 in total

1.  Genetic Characterization of Northwestern Colombian Chikungunya Virus Strains from the 2014-2015 Epidemic.

Authors:  Juan D Rodas; Tiffany Kautz; Erwin Camacho; Luis Paternina; Hilda Guzmán; Francisco J Díaz; Pedro Blanco; Robert Tesh; Scott C Weaver
Journal:  Am J Trop Med Hyg       Date:  2016-07-18       Impact factor: 2.345

2.  Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose.

Authors:  Chad J Roy; A Paige Adams; Eryu Wang; Kenneth Plante; Rodion Gorchakov; Robert L Seymour; Heather Vinet-Oliphant; Scott C Weaver
Journal:  J Infect Dis       Date:  2014-01-07       Impact factor: 5.226

3.  A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.

Authors:  Juan García-Arriaza; Victoria Cepeda; David Hallengärd; Carlos Óscar S Sorzano; Beate Mareike Kümmerer; Peter Liljeström; Mariano Esteban
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

4.  Climate change influences on global distributions of dengue and chikungunya virus vectors.

Authors:  Lindsay P Campbell; Caylor Luther; David Moo-Llanes; Janine M Ramsey; Rogelio Danis-Lozano; A Townsend Peterson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-04-05       Impact factor: 6.237

Review 5.  Invasiveness of Aedes aegypti and Aedes albopictus and Vectorial Capacity for Chikungunya Virus.

Authors:  Leon Philip Lounibos; Laura D Kramer
Journal:  J Infect Dis       Date:  2016-12-15       Impact factor: 5.226

6.  Three-way interactions between mosquito population, viral strain and temperature underlying chikungunya virus transmission potential.

Authors:  Karima Zouache; Albin Fontaine; Anubis Vega-Rua; Laurence Mousson; Jean-Michel Thiberge; Ricardo Lourenco-De-Oliveira; Valérie Caro; Louis Lambrechts; Anna-Bella Failloux
Journal:  Proc Biol Sci       Date:  2014-10-07       Impact factor: 5.349

7.  A chimeric vesiculo/alphavirus is an effective alphavirus vaccine.

Authors:  Anasuya Chattopadhyay; Eryu Wang; Robert Seymour; Scott C Weaver; John K Rose
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

Review 8.  Chikungunya virus and prospects for a vaccine.

Authors:  Scott C Weaver; Jorge E Osorio; Jill A Livengood; Rubing Chen; Dan T Stinchcomb
Journal:  Expert Rev Vaccines       Date:  2012-09       Impact factor: 5.217

Review 9.  Factors shaping the adaptive landscape for arboviruses: implications for the emergence of disease.

Authors:  Lark L Coffey; Naomi Forrester; Konstantin Tsetsarkin; Nikos Vasilakis; Scott C Weaver
Journal:  Future Microbiol       Date:  2013-02       Impact factor: 3.165

10.  Comprehensive Genome Scale Phylogenetic Study Provides New Insights on the Global Expansion of Chikungunya Virus.

Authors:  Rubing Chen; Vinita Puri; Nadia Fedorova; David Lin; Kumar L Hari; Ravi Jain; Juan David Rodas; Suman R Das; Reed S Shabman; Scott C Weaver
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.